How Much Is A Risperdal Gynecomastia Lawsuit Settlement Worth?
Written by Stephen Fields on March 3, 2015
Johnson & Johnson is under increasing scrutiny for failing to warn families about the possible connection between its drug Risperdal and breast development in young boys. Many families have learned the hard way that trusting the pharmaceutical giant’s claim that its antipsychotic medicine is safe presents an enormous risk. Hundreds of Risperdal breast growth lawsuit claims have been filed on behalf of adolescent males injured by the drug.
The development of breasts in boys is called gynecomastia. The disorder can have a severe physical and psychological impact on those who have it. In addition to the disfigurement associated with it, gynecomastia can adversely affect the victim’s self-esteem and mental health. It can even reduce his quality of life.
Parents who have filed claims against Johnson & Johnson allege the company should have been aware of the danger. Some plaintiffs have accused J&J of hiding information about Risperdal side effects in children from the public.
In the first Risperdal lawsuit to go to trial in 2015, former FDA chief David Kessler testified that Johnson & Johnson knew about the Risperdal link to male breast growth more than a decade ago.
That testimony may have been fundamental in the end result when the jury awarded the Risperdal plantiffs $2.5 million in damages for J&J’s failure to warn of gynecomastia risk.
If you or your son experienced abnormal breast growth after taking Risperdal, you may be entitled to receive compensation. Call 1-888-210-9968 to speak with a drug injury attorney about pursuing a Risperdal settlement.
The Problem: Risperdal Gynecomastia In Young Boys
Male breast growth caused by Risperdal may stem from the drug’s effect on the brain chemical dopamine. The drug blocks dopamine receptors. One of the side effects is a dramatic increase in the level of prolactin released by the pituitary gland (known as hyperprolactinaemia).
Elevated levels of prolactin are commonly seen in pregnant women. The hormone contributes to lactation and breast development as well as many other functions.
Raised levels of the hormone can stimulate a similar effect in adolescent boys. Those who have been diagnosed with gynecomastia typically show a high level of prolactin in their blood.
Researchers have found that abnormal breast development can have a severe psychological impact on young boys. A study conducted by doctors at Boston Children’s Hospital revealed some the disorder’s byproducts. It can harm adolescent boys’ self-esteem, impair their ability to interact with their peers and cause them to suffer mental health deficits.
The Solution: Filing A Risperdal Lawsuit For Compensation
Mounting evidence indicates that Johnson & Johnson was aware of the potential for Risperdal to trigger breast growth in young boys. Plaintiffs in the pending Risperdal litigation assert that the company had a responsibility to warn families and physicians. It failed to do so, exposing families to a severe side effect that could have easily been avoided.
This isn’t the first time that Johnson & Johnson has faced lawsuits over its aggressive and misleading advertising of Risperdal. J&J agreed to pay more than $2 billion in 2013 to settle an investigation started by the Department of Justice. In addition, the company settled a number of gynecomastia lawsuits in 2012, notably before the cases went to trial.
If you or your son were harmed by J&J’s antipsychotic drug, you may be able to obtain compensation by filing a claim.
How Much Will You Receive From A Risperdal Lawsuit Settlement?
Hundreds of lawsuits are currently pending against the manufacturer. As more families learn that use of Risperdal may have caused their young boys to suffer abnormal breast growth, that number is sure to climb.
The terms of the Risperdal settlements reached with plaintiffs in 2012 were not disclosed. No one but the victims and their families know how much money Johnson & Johnson was willing to pay to settle the lawsuits.
Today, a Risperdal male breast settlement is likely to take into account the extent to which gynecomastia has impacted the victim. That includes any psychological trauma stemming from disfigurement. It should also include the cost of treatment in cases where the victim has undergone a mastectomy to remove excess breast tissue.
Johnson & Johnson has not yet started settlement negotiations with plaintiffs involved in the growing mass tort. There is still time to file a claim. Call 1-888-210-9968 today for a free, no-obligation case evaluation. If you decide to move forward with a lawsuit, there are no out-of-pocket legal fees unless we recover compensation for you and your family.
Contact us at your earliest convenience to find out the deadline for filing a Risperdal breast growth claim. Our Risperdal attorneys will answer any questions you have regarding your legal options, and aggressively protect your rights.